These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25563139)

  • 1. Inflammatory bowel disease among Bedouin Arabs in southern Israel: urbanization and increasing prevalence rates.
    Abu Freha N; Schwartz D; Elkrinawi J; Ben Yakov G; Abu Tailakh M; Munteanu D; Abu Ganim A; Fich A
    Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):230-4. PubMed ID: 25563139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of inflammatory bowel disease in an Israeli Arab population.
    Zvidi I; Fraser GM; Niv Y; Birkenfeld S
    J Crohns Colitis; 2013 Jun; 7(5):e159-63. PubMed ID: 22921466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
    Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
    BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory bowel disease in an underdeveloped region of Northeastern Brazil.
    Parente JM; Coy CS; Campelo V; Parente MP; Costa LA; da Silva RM; Stephan C; Zeitune JM
    World J Gastroenterol; 2015 Jan; 21(4):1197-206. PubMed ID: 25632193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASCA and ANCA among Bedouin Arabs with inflammatory bowel disease, the frequency and phenotype correlation.
    Abu-Freha N; Badarna W; Sigal-Batikoff I; Abu Tailakh M; Etzion O; Elkrinawi J; Segal A; Mushkalo A; Fich A
    BMC Gastroenterol; 2018 Oct; 18(1):153. PubMed ID: 30342474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory bowel disease in the Bedouin Arabs of southern Israel: rarity of diagnosis and clinical features.
    Odes HS; Fraser D; Krugliak P; Fenyves D; Fraser GM; Sperber AD
    Gut; 1991 Sep; 32(9):1024-6. PubMed ID: 1916484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis.
    Billioud V; Ford AC; Tedesco ED; Colombel JF; Roblin X; Peyrin-Biroulet L
    J Crohns Colitis; 2013 Dec; 7(11):853-67. PubMed ID: 23523418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiology of inflammatory bowel diseases in Veszprém county of Western Hungary between 1977 and 2001].
    Lakatos L; Mester G; Erdélyi Z; Balogh M; Szipócs I; Kamarás G; Lakatos PL
    Orv Hetil; 2003 Sep; 144(37):1819-27. PubMed ID: 14596020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rheumatic complications of inflammatory bowel disease among Arabs: a hospital-based study in Kuwait.
    Al-Jarallah K; Shehab D; Al-Azmi W; Al-Fadli A
    Int J Rheum Dis; 2013 Apr; 16(2):134-8. PubMed ID: 23773636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and Phenotypic Differences in Inflammatory Bowel Disease Among Arab and Jewish Children in Israel.
    Rinawi F; Assa A; Bashir H; Peleg S; Shamir R
    Dig Dis Sci; 2017 Aug; 62(8):2095-2101. PubMed ID: 28547648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of TNF-antagonist switch over time and associated risk factors in the Swiss Inflammatory Bowel Disease Cohort.
    Hiroz P; Vavricka SR; Fournier N; Safroneeva E; Pittet V; Rogler G; Schoepfer AM;
    Scand J Gastroenterol; 2014 Oct; 49(10):1207-18. PubMed ID: 25120029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF-857 polymorphism in Israeli Jewish patients with inflammatory bowel disease.
    Fidder HH; Heijmans R; Chowers Y; Bar-Meir S; Avidan B; Pena AS; Crusius JB
    Int J Immunogenet; 2006 Apr; 33(2):81-5. PubMed ID: 16611251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic management of inflammatory bowel disease in real-life practice in the current era of anti-TNF agents: analysis of the French administrative health databases 2009-2014.
    Kirchgesner J; Lemaitre M; Rudnichi A; Racine A; Zureik M; Carbonnel F; Dray-Spira R
    Aliment Pharmacol Ther; 2017 Jan; 45(1):37-49. PubMed ID: 27781286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease-the Israeli Real-World Experience.
    Kopylov U; Ron Y; Avni-Biron I; Koslowsky B; Waterman M; Daher S; Ungar B; Yanai H; Maharshak N; Ben-Bassat O; Lichtenstein L; Bar-Gil Shitrit A; Israeli E; Schwartz D; Zittan E; Eliakim R; Chowers Y; Ben-Horin S; Dotan I
    Inflamm Bowel Dis; 2017 Mar; 23(3):404-408. PubMed ID: 28178003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar clinical characteristics of familial and sporadic inflammatory bowel disease in South Korea.
    Chung SH; Park SJ; Lee HS; Hong SP; Cheon JH; Kim TI; Kim WH
    World J Gastroenterol; 2014 Dec; 20(45):17120-6. PubMed ID: 25493025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of anti-tumour necrosis factor-α therapy in Danish patients with inflammatory bowel diseases.
    Bank S; Andersen PS; Burisch J; Pedersen N; Roug S; Galsgaard J; Turino SY; Brodersen JB; Rashid S; Avlund S; Olesen TB; Green A; Hoffmann HJ; Thomsen MK; Thomsen VØ; Nexø BA; Vogel U; Andersen V
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthcare Utilisation and Drug Treatment in a Large Cohort of Patients with Inflammatory Bowel Disease.
    Cars T; Wettermark B; Löfberg R; Eriksson I; Sundström J; Lördal M
    J Crohns Colitis; 2016 May; 10(5):556-65. PubMed ID: 26733406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study.
    Charpentier C; Salleron J; Savoye G; Fumery M; Merle V; Laberenne JE; Vasseur F; Dupas JL; Cortot A; Dauchet L; Peyrin-Biroulet L; Lerebours E; Colombel JF; Gower-Rousseau C
    Gut; 2014 Mar; 63(3):423-32. PubMed ID: 23408350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.